Literature DB >> 25070231

Osteosarcoma.

Drew D Moore1, Hue H Luu.   

Abstract

Osteosarcoma is a malignant tumor that primarily affects the long bones but can also involve other bones in the body.  It has a bimodal distribution with peaks in the second decade of life and late adulthood.  This chapter will highlight the clinical presentation, diagnosis, and treatment of osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25070231     DOI: 10.1007/978-3-319-07323-1_4

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  148 in total

1.  S-phase kinase-associated protein 2 promotes cell growth and motility in osteosarcoma cells.

Authors:  Lu Ding; Rong Li; Rongxin Sun; Yang Zhou; Yubo Zhou; Xiaoping Han; Yong Cui; Wu Wang; Qing Lv; Jingping Bai
Journal:  Cell Cycle       Date:  2017-08-03       Impact factor: 4.534

2.  Up-regulation of HDAC9 promotes cell proliferation through suppressing p53 transcription in osteosarcoma.

Authors:  Yu-Xin Zhao; Yi-Sheng Wang; Qi-Qing Cai; Jia-Qiang Wang; Wei-Tao Yao
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma.

Authors:  Wei-Ping Ji; Neng-Bin He
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

4.  Association of GRM4 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma in Guangxi Chinese population.

Authors:  Kun Wang; Jinmin Zhao; Maolin He; Mitra Fowdur; Tenglong Jiang; Shuju Luo
Journal:  Tumour Biol       Date:  2015-08-15

5.  Circular RNA 0001785 regulates the pathogenesis of osteosarcoma as a ceRNA by sponging miR-1200 to upregulate HOXB2.

Authors:  Shenglong Li; Yi Pei; Wei Wang; Fei Liu; Ke Zheng; Xiaojing Zhang
Journal:  Cell Cycle       Date:  2019-05-22       Impact factor: 4.534

6.  Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1.

Authors:  Yang Su; Yan Zhou; Yuan-Jue Sun; Ya-Ling Wang; Jun-Yi Yin; Yu-Jing Huang; Jian-Jun Zhang; Ai-Na He; Kun Han; Hui-Zhen Zhang; Yang Yao; Xiao-Bin Lv; Hai-Yan Hu
Journal:  J Mol Med (Berl)       Date:  2018-11-13       Impact factor: 4.599

7.  Metformin inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the phosphorylation of Akt.

Authors:  Zuohong Li; Lesheng Wang; Nan Luo; Yantao Zhao; Jiazhi Li; Qiwei Chen; Yu Tian
Journal:  Oncol Lett       Date:  2018-03-20       Impact factor: 2.967

8.  Downregulation of miR-19a inhibits the proliferation and promotes the apoptosis of osteosarcoma cells by regulating the JAK2/STAT3 pathway.

Authors:  Jiangqiang Chen; Zuhui Chen
Journal:  Oncol Lett       Date:  2020-08-28       Impact factor: 2.967

9.  Hyperuricemia has an adverse impact on the prognosis of patients with osteosarcoma.

Authors:  Shangzeng Wang; Xiaoya Liu; Zike He; Xinfeng Chen; Wei Li
Journal:  Tumour Biol       Date:  2015-08-18

10.  Porous nano-hydroxyapatite/collagen scaffold containing drug-loaded ADM-PLGA microspheres for bone cancer treatment.

Authors:  Zi-Jie Rong; Lian-Jun Yang; Bao-Ta Cai; Li-Xin Zhu; Yan-Lin Cao; Guo-Feng Wu; Zan-Jie Zhang
Journal:  J Mater Sci Mater Med       Date:  2016-03-14       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.